Dr. Brackett has published more than 200 scientific articles on emotions, decision-making, relationships, health, and performance.
Snapshot · The Mel Robbins Podcast
Dr. Brackett has published more than 200 scientific articles on emotions, decision-making, relationships, health, and performance.
Where this was said
At 2:55 · chapter starts 0:00
Mel Robbins opens the episode with a relatable emotional confession: hitting send on a text you know will cause trouble, picking a fight with your spouse after a hard day, spiraling into negativity before a great opportunity. She names the feeling precisely — being 'stuck in reaction mode' — and poses the episode's central challenge: are you going to keep being controlled by your emotions for the rest of your life? The answer, she promises, is no. She frames emotional intelligence as a learnable skill that 90% of people were never taught, one that affects every domain of life — relationships, health, goals, and attitude. She then introduces Dr. Marc Brackett with his full credentials: founding director of the Yale Center for Emotional Intelligence, professor at the Yale School of Medicine's Child Study Center, author of over 200 scientific papers, advisor to Fortune 500 companies, and New York Times bestselling author of Permission to Feel, translated into 27 languages. The scale of his reach — an EI framework in 5,000 schools, 10 million students — establishes him not as a self-help personality but as a rigorous scientist.
Only one-third of people report having had an adult in childhood who created conditions for them to be their authentic, feeling selves.
An estimated 90% of people were never taught emotional intelligence as a skill, despite it being a primary driver of life outcomes.
Dr. Brackett's evidence-based emotional intelligence framework has been implemented in more than 5,000 schools serving over 10 million students.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.